Position in ALKS
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$14,827
+$4,821 QoQ
Shares Held
283
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#73
of 106 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Private Wealth Management Group, LLC holds $112,918 across 17 Drug Manufacturers - Specialty & Generic names. ALKS ranks #3 (13.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
1,045 | $16,594 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
648 | $15,947 | |
| 3 | ALKS |
Alkermes plc.
This page
|
283 | $14,827 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
27 | $14,629 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
83 | $13,988 | |
| 6 | INM |
InMed Pharmaceuticals Inc.
|
5,000 | $7,750 | |
| 7 | ANIK |
Anika Therapeutics, Inc.
|
522 | $7,636 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
64 | $7,100 |
All Filings in ALKS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,827 | 283 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $10,006 | 283 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $7,974 | 285 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $8,700 | 290 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $8,296 | 290 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $9,575 | 290 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $8,340 | 290 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $8,117 | 290 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $6,989 | 290 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,055 | 39 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $499 | 18 | Shares | Sole | 2024-02-08 | |
| No filing history on record for this holder in this stock. | ||||||